Edition:
United States

Sartorius Stedim Biotech SA (STDM.PA)

STDM.PA on Paris Stock Exchange

113.30EUR
11:37am EDT
Change (% chg)

€0.80 (+0.71%)
Prev Close
€112.50
Open
€112.70
Day's High
€113.70
Day's Low
€112.50
Volume
49,863
Avg. Vol
53,042
52-wk High
€113.70
52-wk Low
€50.13

Summary

Name Age Since Current Position

Joachim Kreuzburg

53 2007 Chairman of the Board and Chief Executive Officer, Chairman of the Executive Committee

Lothar Kappich

61 2017 Non-Executive Director

Bernard Lemaitre

79 2007 Non-Executive Director

Liliane de Lassus

74 2006 Non-Executive Independent Director

Susan Dexter

62 2015 Non-Executive Independent Director

Anne-Marie Graffin

57 2015 Non-Executive Independent Director

Henri Riey

56 2007 Non-Executive Independent Director

Petra Kirchhoff

2018 Vice President of Corporate Communications and Investor Relations

Biographies

Name Description

Joachim Kreuzburg

Dr. Joachim Kreuzburg has served as Chairman of the Board and Chief Executive Officer, Chairman of the Executive Committee of Sartorius Stedim Biotech SA since June 29, 2007. He is also Member of the Company's Remuneration Committee. In addition to his duties at the Company, Dr. Kreuzburg held several other mandates, including Vice Chairman of the Supervisory Board of Sartorius Stedim Biotech GmbH and Member of the Board of Directors of Sartorius Mechatronics Japan K.K., among others. He started his career working as a Scientific Assistant at the Research Institute on Solar Energy of Lower Saxony from 1992 to 1995. Subsequently, he was Scientific Assistant at the department of Economics of Hannover University until 1999. He then joined Sartorius AG as Director of Finance and Investors Relations on May 1, 1999. In November 2002, he was appointed Member of the Management Board of Sartorius AG and Director of Finance, Administration and Investors Relations. Between May 2003 and November 2005, Dr. Kreuzburg served as Spokesperson of the Management Board of Sartorius AG. Since November 11, 2005, he has been Chairman of the Management Board of Sartorius AG. Dr. Kreuzburg holds a degree in Mechanical Engineering from Gottfried Wilhelm Leibniz Universitaet Hannover (Hannover University), a Doctorate degree in Political Science and a Doctorate degree in Economics.

Lothar Kappich

Dr. Lothar Kappich has been Non-Executive Director of Sartorius Stedim Biotech S.A. since September 14, 2017. Since 2017, he has been Chairman of the Supervisory Board of Sartorius AG, Goettingen which he joined as its Member in 2007. From 1990 to 2017, he served for ECE Projektmanagement G.m.b.H. & Co. KG in Hamburg. Previously, Dr. Kappich was Controller in the Central Controlling Department from Schering AG in Berlin from 1988 to 1990. He holds doctorate in economics.

Bernard Lemaitre

Mr. Bernard Lemaitre has served as Non-Executive Director of Sartorius Stedim Biotech SA as of June 29, 2007. He is also Member of the Company's Audit Committee and the Remuneration Committee. Mr. Lemaitre is the founder of Stedim S.A. and served as its Chairman of the Board and Chief Executive Officer from 1979 until 2007. He currently occupies several other posts, including Chairman of Financiere de la Seigneurie S.A.S., Director at Senova Systems Inc., and Member of the Supervisory Board of Qualium Investments SAS, among others.

Liliane de Lassus

Ms. Liliane de Lassus has served as Non-Executive Idependent Director of at Sartorius Stedim Biotech SA since May 19, 2006. She is also Member of the Audit and Remuneration Committees of the Company. Ms. de Lassus has been also Manager of L2L Conseils SARL, as of May 2008. She previously worked for the Company as Deputy Chief Executive Officer - Finance, Human Resources and Information Technology; Member of the Executive Committee; Executive Director of the Company between June 29, 2007 and March 31, 2008. Prior to that, she served as Chief Executive Officer of Stedim Biosystems from 2005 to 2007. She then worked as Director of Planning and Manufacturing for PSA - Automobiles Citroen until 1981 and subsequently as Head of Strategic Planning of Renault Automation until 1985. She then headed her own artificial intelligence company, Cognitech, holding the positions of Chairman of the Board and Chief Executive Officer, before serving, from 1989, as a Consultant in Human Resources Management to multinational executives. Ms. de Lassus began her career in the area of research at the CNRS in France, and Berkeley University, United States from 1969 until 1977. She obtained a Ph.D. degree in Organic Chemistry in 1972, a Masters of Business Administration degree from Institut d'Administration des Entreprises in 1966 and a Masters degree in Sanskrit in 1969.

Susan Dexter

Ms. Susan J. Dexter has been Non-Executive Independent Board Member of Sartorius Stedim Biotech SA since April 7, 2015. Previously, she was Board Member of BioSense Technologies and Chief Medical Officer of Kalon Biotherapeutics. She holds double major (Immunology and Marketing) Bachelor of Science degree from American University in Washington. She attended also courses at Harvard University, Negotiation Course for Lawyers among others.

Anne-Marie Graffin

Ms. Anne-Marie Graffin has been Non-Executive Independent Board Member of Sartorius Stedim Biotech SA since April 7, 2015. She has also served as Member of the Supervisory Board of Valneva S.E. and Nanobiotix SA as wall as Managing Director of SMAG Consulting SARL. She was Board Member of Themis Bioscience GmbH. From 1998 until 2010, she held various positions at Sanofi Pasteur MSD, latest being Vice President Business Management. She graduated from Ecole Superieure des Sciences Economiques et Commerciales (ESSEC).

Henri Riey

Mr. Henri Riey has served as Non-Executive Independent Director of Sartorius Stedim Biotech SA as of June 29, 2007. He is also Member of the Remuneration Committee and since December 5, 2007 he has served as Chairman of Company's Audit Committee. Mr. Riey holds a degree from Institut Superieur de Gestion (ISG) and began his career as Fund Manager at BNP Paribas in 1985. In 1988, he joined Barclays in France as Fund Manager and Head of the European Securities Management team. He was subsequently appointed Director of Research of Barclays Asset Management Europe in 1996 and then Vice President of Barclays Asset Management in charge of all fund management activities in 1999. From 2004 to 2013, Mr. Riey has been Director of Finance at Hendyplan S.A. He currently serves as President of Aidea, President of Group HR SAS and Director of The Princess Grace Foundation in Monaco.

Petra Kirchhoff

Basic Compensation

Name Fiscal Year Total

Joachim Kreuzburg

1,867,000

Lothar Kappich

38,200

Bernard Lemaitre

52,200

Liliane de Lassus

52,200

Susan Dexter

37,400

Anne-Marie Graffin

36,200

Henri Riey

55,000

Petra Kirchhoff

--
As Of  30 Dec 2017